A crossover novel between Science Fiction and LabLit the story tracks two young people working in big pharma. By 2032 advances in epigenetic therapeutics have produced a healthier population, but all is not well in the healthcare industry. Two young workers discover the price that the older population are having to pay. They act as whistleblowers and pay a high price for their efforts.